Phenotypic correlations in FTDP-17

被引:174
|
作者
Reed, LA [1 ]
Wszolek, ZK
Hutton, M
机构
[1] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
关键词
frontotemporal dementia; parkinsonism; tau; FTDP-17; hereditary neurodegenerative disease; alternative splicing;
D O I
10.1016/S0197-4580(00)00202-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Frontotemporal dementias with parkinsonism linked to chromosome 17 (FTDP-17) are hereditary tauopathies affecting at least 50 known kindred worldwide. Most kindred present with severe behavioral or psychiatric manifestations progressing to dementia, while some kindred first manifest a parkinsonian-plus syndrome. Nine missense mutations, one deletion mutation, and two transition mutations not altering the encoded amino acid, have been described in or near the microtubule-binding domains within exons 9, 10, 12, and 13. In addition, five different intronic mutations have been reported in the 5' splice-site of the alternatively spliced exon 10. Missense mutations affecting constitutively expressed exons affect all six major tan isoforms and result in neurofibrillary tangles similar to those present in secondary tauopathies, such as Alzheimer's disease. In contrast, mutations that affect the alternatively spliced exon 10 or its: 5' splice regulatory region alter the ratio of the tau isoforms incorporated into the tangles acid result in filamentous inclusions resembling those seen in the primary tauopathies, such as progressive supranuclear palsy, corticobasal degeneration, and Pick's disease. The severity and heterogeneity of the clinicomorphologic phenotype may, in part, reflect the diversity in the primary molecular mechanisms of disease in FTDP-17. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:89 / 107
页数:19
相关论文
共 50 条
  • [1] Visual grasping in FTDP-17
    Ogaki, K.
    Li, Y.
    Motoi, Y.
    Shimizu, N.
    Takanashi, M.
    Machida, Y.
    Nakamura, S. -I.
    Yokoyama, K.
    Hattori, N.
    MOVEMENT DISORDERS, 2008, 23 (01) : S250 - S251
  • [2] Rest in peace FTDP-17
    Josephs, Keith A.
    BRAIN, 2018, 141 : 324 - 326
  • [3] Refining frontotemporal dementia with parkinsonism linked to chromosome 17 -: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN)
    Boeve, Bradley F.
    Hutton, Mike
    ARCHIVES OF NEUROLOGY, 2008, 65 (04) : 460 - 464
  • [4] Olfactory dysfunction in FTDP-17/PPND
    Schweitzer, Katherine J.
    Dickson, Dennis W.
    Stongosky, Audrey
    Hentschel, Kenneth
    Williams, Lindsey
    Wszolek, Zbigniezv K.
    ANNALS OF NEUROLOGY, 2008, 64 : S49 - S49
  • [5] Dephosphorylation of FTDP-17 mutant tau
    Asada, Akiko
    Yotsumoto, Kensuke
    Saito, Taro
    Oikawa, Takayuki
    Ishiguro, Koichi
    Uchida, Takafumi
    Hasegawa, Masato
    Hisanaga, Shin-Ichi
    NEUROSCIENCE RESEARCH, 2008, 61 : S263 - S263
  • [6] The genetics of PSP/CBD and FTDP-17
    Hutton, M
    MOVEMENT DISORDERS, 2002, 17 (06) : 1402 - 1403
  • [7] Pick's complex and FTDP-17
    Kertesz, A
    MOVEMENT DISORDERS, 2003, 18 : S57 - S62
  • [8] Phenotypic heterogeneity of FTDP-17: implications for the differences of pathological phenotype among sporadic tauopathies
    Arai, T
    Ikeda, K
    NEUROBIOLOGY OF AGING, 2001, 22 (01) : 127 - 129
  • [9] MRI findings in FTDP-17 with MAPT mutations
    Frank, AR
    Wszolek, ZK
    Jack, CR
    Knopman, DS
    Boeve, BF
    Petersen, RC
    NEUROLOGY, 2006, 66 (05) : A54 - A55
  • [10] Genotype-phenotype correlations in FTDP-17: does form follow function? Commentary
    Forman, MS
    EXPERIMENTAL NEUROLOGY, 2004, 187 (02) : 229 - 234